|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parkin DM, Bray F, Ferlay and Pisani P:
Global cancer statistics 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mirnezami AH, Pickard K, Zhang L, Primrose
JN and Packham G: MicroRNAs: key players in carcinogenesis and
novel therapeutic targets. Eur J Surg Oncol. 35:339–347. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruan K, Fang X and Ouyang G: MicroRNAs:
novel regulators in the hallmarks of human cancer. Cancer Lett.
285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim K, Chadalapaka G, Pathi SS, et al:
Induction of the transcriptional repressor ZBTB4 in prostate cancer
cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Mol Cancer Ther. 11:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Selcuklu SD, Donoghue MT, Rehmet K, et al:
MicroRNA-9 inhibition of cell proliferation and identification of
novel miR-9 targets by transcriptome profiling in breast cancer
cells. J Biol Chem. 287:29516–29528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dey N, Das F, Ghosh-Choudhury N, et al:
microRNA-21 governs TORC1 activation in renal cancer cell
proliferation and invasion. PLoS One. 7:e373662012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He HC, Zhu JG, Chen XB, et al:
MicroRNA-23b downregulates peroxiredoxin III in human prostate
cancer. FEBS Lett. 586:2451–2458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hur K, Toiyama Y, Takahashi M, et al:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Leva G, Piovan C, Gasparini P, et al:
Estrogen mediated-activation of miR-191/425 cluster modulates
tumorigenicity of breast cancer cells depending on estrogen
receptor status. PLoS Genet. 9:e10033112013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng WZ, Ma R, Wang F, Yu J and Liu ZB:
Role of miR-191/425 cluster in tumorigenesis and diagnosis of
gastric cancer. Int J Mol Sci. 15:4031–4048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sander S, Bullinger L, Klapproth K,
Fiedler K, et al: MYC stimulates EZH2 expression by repression of
its negative regulator miR-26a. Blood. 112:4202–4212. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jazbutyte V and Thum T: MicroRNA-21: from
cancer to cardiovascular disease. Current Drug Targets. 11:926–935.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uziel T, Karginov FV, Xie S, Parker JS, et
al: The miR-17∼92 cluster collaborates with the Sonic Hedgehog
pathway in medulloblastoma. Proc Natl Acad Sci USA. 106:2812–2817.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bryant RJ, Pawlowski T, Catto JW, Marsden
G, et al: Changes in circulating microRNA levels associated with
prostate cancer. Br J Cancer. 106:768–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang M, Gu H, Qian H, Zhu W, et al:
miR-17-5p/20a are important markers for gastric cancer and murine
double minute 2 participates in their functional regulation. Eur J
Cancer. 49:2010–2021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mavrakis KJ, Wolfe AL, Oricchio E,
Palomero T, et al: Genome-wide RNA-mediated interference screen
identifies miR-19 targets in Notch-induced T-cell acute
lymphoblastic leukaemia. Nat Cell Biol. 12:372–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsu KW, Wang AM, Ping YH, Huang KH, et al:
Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric
carcinogenesis. Carcinogenesis. 35:208–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma J, Liu J, Wang Z, et al:
NF-kappaB-dependent microRNA-425 upregulation promotes gastric
cancer cell growth by targeting PTEN upon IL-1beta induction. Mol
Cancer. 13:402014. View Article : Google Scholar : PubMed/NCBI
|
